CADL
Price
$6.22
Change
+$0.09 (+1.47%)
Updated
Jan 14, 04:59 PM (EDT)
Capitalization
336.53M
71 days until earnings call
Intraday BUY SELL Signals
RPTX
Price
$2.60
Change
+$0.02 (+0.77%)
Updated
Jan 14, 04:59 PM (EDT)
Capitalization
111.44M
48 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CADL vs RPTX

Header iconCADL vs RPTX Comparison
Open Charts CADL vs RPTXBanner chart's image
Candel Therapeutics
Price$6.22
Change+$0.09 (+1.47%)
Volume$12.21K
Capitalization336.53M
Repare Therapeutics
Price$2.60
Change+$0.02 (+0.77%)
Volume$14.89K
Capitalization111.44M
CADL vs RPTX Comparison Chart in %
CADL
Daily Signal:
Gain/Loss:
RPTX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CADL vs. RPTX commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CADL is a Hold and RPTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (CADL: $6.13 vs. RPTX: $2.59)
Brand notoriety: CADL and RPTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CADL: 108% vs. RPTX: 36%
Market capitalization -- CADL: $336.53M vs. RPTX: $111.44M
CADL [@Biotechnology] is valued at $336.53M. RPTX’s [@Biotechnology] market capitalization is $111.44M. The market cap for tickers in the [@Biotechnology] industry ranges from $115.36B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CADL’s FA Score shows that 0 FA rating(s) are green whileRPTX’s FA Score has 0 green FA rating(s).

  • CADL’s FA Score: 0 green, 5 red.
  • RPTX’s FA Score: 0 green, 5 red.
According to our system of comparison, RPTX is a better buy in the long-term than CADL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CADL’s TA Score shows that 4 TA indicator(s) are bullish while RPTX’s TA Score has 4 bullish TA indicator(s).

  • CADL’s TA Score: 4 bullish, 5 bearish.
  • RPTX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, RPTX is a better buy in the short-term than CADL.

Price Growth

CADL (@Biotechnology) experienced а +9.86% price change this week, while RPTX (@Biotechnology) price change was +0.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.47%. For the same industry, the average monthly price growth was +3.44%, and the average quarterly price growth was +44.89%.

Reported Earning Dates

CADL is expected to report earnings on Mar 26, 2026.

RPTX is expected to report earnings on Mar 03, 2026.

Industries' Descriptions

@Biotechnology (+0.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CADL($337M) has a higher market cap than RPTX($111M). CADL YTD gains are higher at: 8.496 vs. RPTX (-0.577). CADL has higher annual earnings (EBITDA): -20.74M vs. RPTX (-76.46M). RPTX has more cash in the bank: 113M vs. CADL (87M). RPTX has less debt than CADL: RPTX (342K) vs CADL (7.21M). RPTX has higher revenues than CADL: RPTX (11.9M) vs CADL (0).
CADLRPTXCADL / RPTX
Capitalization337M111M304%
EBITDA-20.74M-76.46M27%
Gain YTD8.496-0.577-1,473%
P/E RatioN/AN/A-
Revenue011.9M-
Total Cash87M113M77%
Total Debt7.21M342K2,107%
TECHNICAL ANALYSIS
Technical Analysis
CADLRPTX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
83%
Declines
ODDS (%)
Bearish Trend 10 days ago
89%
Bearish Trend 7 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
Aroon
ODDS (%)
Bearish Trend 7 days ago
88%
Bullish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
CADL
Daily Signal:
Gain/Loss:
RPTX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BSPK0.20N/A
+1.95%
Bespoke Extracts, Inc.
EMBVF10.99N/A
N/A
Arca Continental SAB de CV
KMRCF9.42N/A
N/A
Komori Corp.
MOHCY15.33N/A
N/A
Motor Oil (Hellas) Corinth Refineries S.A.
CJAX3.55N/A
N/A
COJAX OIL & GAS CORP.

CADL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CADL has been loosely correlated with RXRX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CADL jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CADL
1D Price
Change %
CADL100%
+4.61%
RXRX - CADL
46%
Loosely correlated
-2.49%
CYYNF - CADL
46%
Loosely correlated
N/A
RPTX - CADL
44%
Loosely correlated
+0.58%
RGNX - CADL
42%
Loosely correlated
-0.20%
CRSP - CADL
41%
Loosely correlated
+1.59%
More

RPTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RPTX has been loosely correlated with INO. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if RPTX jumps, then INO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RPTX
1D Price
Change %
RPTX100%
+0.58%
INO - RPTX
47%
Loosely correlated
+3.90%
CADL - RPTX
39%
Loosely correlated
+4.61%
ZYME - RPTX
39%
Loosely correlated
+3.28%
JAZZ - RPTX
38%
Loosely correlated
-0.76%
ALNY - RPTX
38%
Loosely correlated
-0.26%
More